Skip to content

Hoffie.net

  • Beauty & Balance
  • Health News
  • Wellness
  • Online

Home ยป Administrat

U.S. Food and Drug Administration Approves Opdivo (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma

August 30, 2021 Health News Comments Off on U.S. Food and Drug Administration Approves Opdivo (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma
Recent Posts
  • Football linked to more brain damage beyond white matter marks
  • Digital health algorithm drastically cuts antibiotic use in Tanzanian children
  • Have yourself a food-safe Christmas
  • Rapidly increasing COVID-19 subvariant JN.1 dominating the Northeast US
  • Study reveals cytoglobin's pivotal role in cilia movement and organ positioning during development
Copyright © 2024
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok